aXichem AB

AXIC-A · Nasdaq Stockholm · Basic materials

1.90SEK −5.0%last day

Price as of 2 October 2026

The price over the past year, with dividends: −40.1%

Performance

1 month

−5.0%

1 year

−40.1%

3 years, per year

−39.6%

5 years, per year

−41.2%

Largest fall, 3 years

−96.7%

Below the peak now

−97.9%

Volatility, 1 year

92.3%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

2.2

Dividend yield

0.0%

Return on equity

−28.1%

Net margin

−95.4%

Market value

13 m USD

Quality, value and trend

Where aXichem stands against every Nordic stock today. 100 is best.

Quality81

Profitability and a sound balance sheet over time. Better than 81% of Nordic stocks.

Value14

The price measured against earnings, assets and cash flow. Better than 14% of Nordic stocks.

Trend32

The price development over the past year. Better than 32% of Nordic stocks.

Combined32

Quality, value and trend together. Better than 32% of Nordic stocks.

About aXichem

aXichem AB is a company in basic materials, listed on Nasdaq Stockholm. The share trades in SEK. It has around 7 employees.

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen, a solution for improved health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis